MAUDE Adverse Event Report: MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

Catalog Number	SMXP140RH
Medical Device Problem Code	Material Rupture (1546)
Health Effect - Clinical Code	No Code Available (3191)
Date of Event	07/27/2018
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
The mentor failure analysis lab has received the device for evaluation.The analysis has begun, but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.The device history record (dhr) was reviewed, and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.Concomitant products: 600cc artoura breast tissue expander, catalog #smxp140rh, serial (b)(4).Manufacturer¿s reference number: (b)(4).
Event or Problem Description
It was reported that a (b)(6) female underwent breast reconstruction with 600cc artoura breast tissue expanders.On (b)(6) 2018 left sided deflation was first noticed, and right sided deflation was noticed on (b)(6) 2018.As a result, bilateral replacement with 790cc mentor memorygel breast implants.(see 1645337-2018-05960 for contralateral prosthesis report).
Additional Manufacturer Narrative
The evaluation of the returned device was completed by the failure analysis lab on 10/11/2018.Device evaluation summary: it was reported that a 48-year-old female underwent breast reconstruction with 600cc artoura breast tissue expanders.On (b)(6) 2018 left sided deflation was first noticed, and right sided deflation was noticed on (b)(6) 2018.Upon receipt by mentor, the device returned with white fluid.No foreign material was observed within the device or on the shell surface.The mentor product analysis lab discovered a rent at the posterior aspect.No other anomalies were discovered.The complaint was confirmed since a rupture was found on the device.However, at this point it is not possible to determine the root cause of such damage.There is no evidence that the issue is related with manufacturing.Because the mentor product analysis lab was unable to confirm any unusual failure mode, no corrective action will be taken at this time.Breast implants are not considered lifetime devices and deflation is a known complication associated with these devices and is referenced in our product insert data sheet.Manufacturer¿s reference number: (b)(4).
Additional Manufacturer Narrative
On (b)(6) 2018 mentor became aware that the incorrect event date was submitted with the initial report on (b)(6) 2018.Manufacturer¿s reference number: (b)(4).

• Brand Name: ARTOURA BREAST TISSUE EXPANDER
• Common Device Name: EXPANDER, SKIN, INFLATABLE
• Manufacturer (Section D): MENTOR TEXAS; 3041 skyway circle north; irving TX 75038
• MDR Report Key: 7930569
• Report Number: 1645337-2018-05961
• Device Sequence Number: 11125217
• Product Code: LCJ
• UDI-Device Identifier: 00081317024330
• UDI-Public: 00081317024330
• Combination Product (Y/N): N
• Initial Reporter State: KY
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Device Explanted Year: 2018
• Reporter Type: Manufacturer
• Report Source: user facility
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 09/07/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 03/14/2022
• Device Catalogue Number: SMXP140RH
• Device Lot Number: 7561632
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 09/13/2018
• Initial Date Received by Manufacturer: 10/03/2018
• Supplement Date Received by Manufacturer: 10/03/2018; 10/11/2018
• Initial Report FDA Received Date: 10/03/2018
• Supplement Report FDA Received Date: 10/03/2018; 10/15/2018
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 48 YR